Brighton Jones LLC Biogen Inc. Transaction History

Brighton Jones LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$194.69 - $268.46 $157,504 - $217,184	809 New	809 $216,000
Q4 2021 Feb 03, 2022	SELL	$223.92 - $287.77 $186,525 - $239,712	-833 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$282.99 - $369.05 $235,730 - $307,418	833 New	833 $236,000
Q4 2018 Feb 08, 2019	SELL	$278.5 - $352.75 $158,745 - $201,067	-570 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$293.51 - $383.83 $167,300 - $218,783	570 New	570 $201,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

Stay updated on Brighton Jones LLC with notifications on news.